BRENNER RANDALL B. (Chief Development & Regulatory) sold 6.2% of their position (27.60K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $60.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/10/2023ACC: 0000904454-23-000478
Officer· Chief Development & Regulatory
Since Sep 2019
+39.90K
Net shares
Net buyer
$60.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
67.50K acquired · 27.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+67.50K
Price / share
—
Trade value
—
% of position
18.0%
8/8/2023
375.31K→442.81K
Common Stock
Direct
Shares
−27.60K
Price / share
$2.20
Trade value
$60.73K
% of position
6.2%
8/9/2023
442.81K→415.21K
Total
Net shares
+39.90K
Net value
-$60.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2023 | A · Award | +67.50K | — | — | 18.0% | 375.31K | 442.81K |
| Common Stock Direct | 8/9/2023 | S · Sale | −27.60K | $2.20 | $60.73K | 6.2% | 442.81K | 415.21K |
| Total | +39.90K | -$60.73K | ||||||
Derivative Transactions0
No derivative transactions reported